Alzheimer's
-
healthHealth Canada Approves Second Drug to Slow Alzheimer's Progression
Donanemab, approved in Canada, offers hope by slowing early Alzheimer's decline, targeting amyloid plaques.
-
health6 Common Medications That May Lower Your Dementia Risk
Studies suggest flu shots, shingles vaccines, and other common drugs may reduce dementia risk. Here's what the latest research shows.
-
healthFour Drug Types Linked to Higher Dementia Risk
Common medications, including antihistamines and antipsychotics, may increase dementia risk. Learn which drugs to avoid.
-
healthScientists Identify Brain's 'Molecular Switch' Protecting Against Alzheimer's Decline
New research reveals a protein, chromogranin A, may be key to cognitive resilience in Alzheimer's, offering potential therapeutic targets.
-
healthNew Blood Test Shows Promise for Early Alzheimer's Prediction
Groundbreaking research indicates a blood biomarker, pTau217, could identify Alzheimer's risk years before symptoms manifest, potentially revolutionizing early detection and intervention.
-
healthAlzheimer's Gene APOE4 Disrupts Brain Activity Years Before Symptoms Appear
New research reveals how the APOE4 gene variant alters neuron function, potentially leading to reversible damage and offering new therapeutic avenues for Alzheimer's.
-
healthStudy links higher unprocessed meat intake to lower dementia risk for APOE gene carriers
Research suggests unprocessed meat may reduce dementia risk in older adults with specific APOE gene variants, according to a long-term study.
-
healthSpeech Speed May Signal Early Cognitive Decline
New research links slower speech and longer pauses to early signs of Alzheimer's, even before symptoms appear.